Rare diseases
Investigational molecules
Locations
Back to Greece252 clinical trials in Heraklion, Greece across 1 research site. Every trial is listed in the EU Clinical Trials Register and updated daily.
Study on Asundexian and Apixaban for Preventing Stroke in Adults with Atrial Fibrillation at Risk for Stroke
GreeceStudy of MK-7684A with Chemoradiotherapy Compared to Chemoradiotherapy with Durvalumab for Patients with Stage III Non-Small Cell Lung Cancer
GreeceStudy on the Effects of MBS2320 for Patients with Idiopathic Pulmonary Fibrosis (IPF)
GreeceStudy on the Effectiveness and Safety of RO7434656 for Patients with Primary IgA Nephropathy at High Risk of Progression
GreeceStudy Comparing Upadacitinib and Adalimumab for Adults with Moderate to Severe Rheumatoid Arthritis Not Responding to a Single TNF Inhibitor
GreeceStudy on Upadacitinib for Children with Moderate to Severe Ulcerative Colitis
GreeceStudy on the Long-Term Safety and Effectiveness of Upadacitinib for Patients with Moderate to Severe Crohn's Disease
GreeceStudy on the Long-term Safety and Effectiveness of Sibeprenlimab for Patients with Immunoglobulin A Nephropathy (IgAN)
GreeceStudy on the Effects of Upadacitinib in Adults with Moderate to Severe Systemic Lupus Erythematosus (SLE)
GreeceStudy of Pembrolizumab and Olaparib with Chemoradiation for Patients with Newly Diagnosed Limited-Stage Small Cell Lung Cancer
GreeceStudy on Frexalimab for Treating Active Systemic Lupus Erythematosus in Patients
GreeceStudy on Sibeprenlimab for Patients with IgA Nephropathy
GreeceThe busiest research cities in the country
What the registry says about research in the country
Groundbreaking research focusing on systemic lupus erythematosus and cutaneous lupus, evaluating novel therapeutic approaches. Studies aim to assess treatment effectiveness and long-term safety profiles.
Multiple trials exploring innovative medications for chronic autoimmune conditions.
Comprehensive studies investigating treatments for inflammatory bowel diseases, including trials for both mild and severe cases. Research focuses on combination therapies and long-term management strategies.
Advanced therapeutic approaches for chronic digestive conditions.
Innovative trials targeting various forms of lung cancer and breast cancer, with a focus on advanced and metastatic disease states. Studies evaluate new combination therapies and treatment approaches.
Exploring breakthrough treatments in cancer care.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
